Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
145.95B
Market cap145.95B
Price-Earnings ratio
14.66
Price-Earnings ratio14.66
Dividend yield
6.84%
Dividend yield6.84%
Average volume
49.85M
Average volume49.85M
High today
$25.74
High today$25.74
Low today
$25.35
Low today$25.35
Open price
$25.63
Open price$25.63
Volume
21.14M
Volume21.14M
52 Week high
$27.69
52 Week high$27.69
52 Week low
$20.92
52 Week low$20.92

Stock Snapshot

Pfizer(PFE) stock is priced at $25.67, giving the company a market capitalization of 145.95B. It carries a P/E multiple of 14.66 and pays a dividend yield of 6.8%.

As of 2025-12-04, Pfizer(PFE) stock has fluctuated between $25.35 and $25.74. The current price stands at $25.67, placing the stock +1.3% above today's low and -0.3% off the high.

Pfizer(PFE) shares are trading with a volume of 21.14M, against a daily average of 49.85M.

In the last year, Pfizer(PFE) shares hit a 52-week high of $27.69 and a 52-week low of $20.92.

In the last year, Pfizer(PFE) shares hit a 52-week high of $27.69 and a 52-week low of $20.92.

PFE News

Simply Wall St 18h
Does PADCEV Keytruda Bladder Cancer Win Reshape The Bull Case For Pfizer?

Pfizer and Astellas previously announced that the FDA approved PADCEV (enfortumab vedotin-ejfv) plus Keytruda as a perioperative treatment for cisplatin-ineligi...

Does PADCEV Keytruda Bladder Cancer Win Reshape The Bull Case For Pfizer?
Nasdaq 1d
PFE June 2027 Options Begin Trading

Investors in Pfizer Inc (Symbol: PFE) saw new options become available today, for the June 2027 expiration. One of the key data points that goes into the price...

PFE June 2027 Options Begin Trading
The Motley Fool 4d
This 7% Yielder Could Be a Top AI Play

One drug developer could be on the cusp of AI-powered glory. Shares of the pharmaceutical giant Pfizer (PFE 0.04%) have suffered over the last three years, fal...

This 7% Yielder Could Be a Top AI Play

Analyst ratings

57%

of 28 ratings
Buy
39.3%
Hold
57.1%
Sell
3.6%

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.